SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017061
Filing Date
2024-05-15
Accepted
2024-05-15 16:15:54
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20240331_10q.htm   iXBRL 10-Q 730068
2 EXHIBIT 31.1 ex_613980.htm EX-31.1 16151
3 EXHIBIT 31.2 ex_613981.htm EX-31.2 14648
4 EXHIBIT 32.1 ex_613982.htm EX-32.1 8302
  Complete submission text file 0001437749-24-017061.txt   3940379

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20240331.xsd EX-101.SCH 37718
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20240331_cal.xml EX-101.CAL 18508
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20240331_def.xml EX-101.DEF 275066
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20240331_lab.xml EX-101.LAB 260154
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20240331_pre.xml EX-101.PRE 293654
47 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20240331_10q_htm.xml XML 488926
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 24950974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)